Novel Fluorophore Helps Reduce Surgical Risk in Patients Undergoing Prostatectomy
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, host Rick Greene, MD, FACS, talks with Samuel A. Gold, MD, from the urology service in the Department of Surgery at Memorial Sloan Cancer Center in New York, New York, about using intraoperative fluorescence to illuminate nerve structures during robotic-assisted prostatectomy. Dr. Gold’s phase-1 study, published in JAMA Surgery (Rizedisben in Minimally Invasive Surgery), found that the fluorophore was generally well tolerated and clinically effective, which could revolutionize prostatic surgery and lead to wider applicability.
Talk about the podcast on social media using the hashtag #SurgicalReadings